From the Sector

At ITMA 2023 in Milan from June 8-14 this year, Monforts is organising two free-to-attend seminars and discussions on the potential of green hydrogen as a new energy source for textile finishing, drying and related processes.

Monforts is currently leading a consortium of industrial partners and universities in the three-year WasserSTOFF project, launched in November 2022, that is exploring all aspects of this exciting and fast-rising new industrial energy option.
The target of the government-funded project is to establish to what extent hydrogen can be used in the future as an alternative heating source for textile finishing processes. This will first involve tests on laboratory equipment together with associated partners and the results will then be transferred to a stenter frame at the Monforts Advanced Technology Center (ATC).

To be considered “green”, hydrogen must be produced using a zero-carbon process that is powered by renewable energy sources such as wind or solar. Currently, the cleanest method of hydrogen production is electrolysis, using an electrically-powered electrolyzer to separate water molecules into hydrogen and oxygen. The purity of the hydrogen is also important, and impurities must be removed via a separation process.

“Despite all its advantages, there are obstacles to overcome on the way to widespread, economically-feasible green hydrogen use,” explains Monforts Textile Technologies Engineer Jonas Beisel. “Until there are widely available, reliable and economical sources of this clean power, the cost of producing it will remain prohibitive. The infrastructure is not yet there, and hydrogen also has a tendency to make steel brittle and subject to fracture, which is something that requires further investigation in both its transportation and use in industrial processing.
“Green energy’s potential as a clean fuel source is tremendous, but there is much we need to explore when considering its use in the textile finishing processes carried out globally on our industry-leading Montex stenter dryers and other machines.”

At its Advanced Technology Center (ATC) in Mönchengladbach, Monforts will be carrying out intensive tests and trials to assess the reliability of both processes and final products when different natural gas and hydrogen mixtures – up to 100% green hydrogen – are employed. The results will be closely analysed by the consortium partners because there are many parameters that at this stage remain unknown.

The aim, Beisel adds, is to both reduce CO₂ emissions and – following the rising prices and industry turbulence experienced by manufacturers over the past year or so – to further reduce a dependency on natural gas.

The three-year WasserSTOFF project is sponsored by Germany’s Federal Ministry for Economic Affairs and Climate Action, and with Monforts at the helm brings together industrial partners Pleva and NTB Nova Textil, with academic input from the Hochschule Niederrhein and the Technical University of Freiberg.

Medizinisch-technischer Fortschritt beruht auf einer engen technologischen Partnerschaft zwischen Komponentenherstellern, Medizinprodukte-Unternehmen und Anwendern. „Wir brauchen eine enge Zusammenarbeit und bessere Vernetzung der Technologiepartner und Expert:innen“, sagten der Geschäftsführer des Bundesverbandes Medizintechnologie (BVMed), Dr. Marc-Pierre Möll, und der Geschäftsführer des Fachverbands für Mikrotechnik (IVAM), Dr. Thomas Dietrich auf der ersten gemeinsamen Konferenz „MedTech Business Connect – A Matchmaking Event“ in Berlin.

Der Fokus der Veranstaltung lag auf der Förderung der Zusammenarbeit zwischen Komponentenherstellern und Medizinprodukte-Unternehmen sowie auf persönlichem „Matchmaking“ zu Themen wie Supply Chain Management, Fördermöglichkeiten, aber auch zu technologischen Themen wie Robotik in der Gesundheitsversorgung oder medizinische Wearables. Fachvorträge kamen unter anderem vom BVMed-Vorsitzenden Dr. Meinrad Lugan, VDI-Technologieberaterin Dr. Monika Weinhold, Robotik-Experte Prof. Dr. Ralf-Joachim Schulz vom St. Marien-Hospital Köln sowie Wearables-Experte Erik Jung vom Fraunhofer IZM. Im "Matchmaking" hatten die Teilnehmenden der beiden Verbände die Möglichkeit, sich in Einzelgesprächen zu spezifischen Themen auszutauschen.

Der BVMed-Vorstandsvorsitzende Dr. Meinrad Lugan betonte in seinem Einführungsvortrag, dass neben einer besseren Vernetzung der Expert:innen und Technologiepartner auch eine bessere Vernetzung der vorhandenen Daten und Versorgungsprozesse ermöglicht werden muss, um die Versorgungssicherheit im Gesundheitssystem zu verbessern: „Für bessere Resilienz und Versorgungssicherheit brauchen wir mehr Transparenz im System – mit Hilfe von Daten auf der Basis internationaler Standards“, so Lugan.

Er berichtete aus einer wertvollen Erkenntnis aus dem Beginn der Corona-Pandemie: Für über 80 Prozent aller versorgungskritischen Medizinprodukte gab es keinen Mangel, sondern ein Verteilungsproblem. Nur für weniger als 20 Prozent relevanter Produkte wäre ein Krisenlager oder eine Krisen-Produktionskapazität erforderlich gewesen. „Den Großteil hätten wir durch smarte digitale Lösungen in den Griff bekommen. Deshalb hat der BVMed als Lösungsangebot an die Politik das Konzept einer Digitalen Bestandsplattform versorgungskritischer Medizinprodukte erarbeitet. Damit hätte die Politik im Krisenfall Transparenz in Echtzeit“, so Lugan. Das Konzept beruhe auf einheitlichen Standards in der elektronischen Kommunikation.

Der Vorsitzende des Gemeinsamen Bundesausschusses (G-BA), Prof. Josef Hecken, hat sich auf der BVMed-Mitgliederversammlung am 18. April 2023 in Berlin für ein Beratungsrecht der Medizinprodukte-Hersteller für die anstehenden Studien zum Nutzennachweis für die Erstattungsfähigkeit der „sonstigen Produkte zur Wundbehandlung“ und für die Verlängerung der Übergangsfrist ausgesprochen. „Wir müssen gemeinsam für das Beratungsrecht kämpfen. Dann haben wir die Basis für die Entwicklung von geeigneten Studienkriterien und müssen solange die Übergangsregelung verlängern“, so Heckens Appell an den Gesetzgeber.

Der BVMed hatte sich wiederholt für ein Beratungsrecht beim G-BA analog zum Arzneimittelbereich ausgesprochen, „um Klarheit und Sicherheit beim Antragsprozess, aber insbesondere zu den Anforderungen an Evidenz und Nutzennachweise zu schaffen“, so BVMed-Ambulant-Expertin Juliane Pohl.

Hintergrund ist, dass für jedes einzelne sogenannte „sonstige Produkt zur Wundbehandlung“ künftig der Nachweis der medizinischen Notwendigkeit im Rahmen eines Antragsverfahrens durch den Hersteller beim G-BA durchgeführt werden muss, bevor das jeweilige Produkt durch die Gesetzliche Krankenversicherung (GKV) erstattet wird. Der G-BA hat bislang jedoch keine Klarheit geschaffen, welche Evidenzkriterien in der Wundversorgung für die erstattungsrelevanten Nutzennachweise Anwendung finden. Im Gesetz fehlt ein entsprechender Beratungsanspruch der Hersteller beim G-BA, der Klarheit in diesen komplexen Fragestellungen schaffen könnte. Betroffen von der neuen Regelung ist eine Vielzahl von Produkten wie etwa silber- oder PHMB-haltigen Wundauflagen, die bislang erstattungsfähig waren. Nach Einschätzung des BVMed sind rund 400 Produkte betroffen, für die – bis Dezember 2023 - ein erfolgreiches Nutzenbewertungsverfahren zur Aufnahme in die Anlage V der geänderten Arzneimittel-Richtlinie erforderlich wird.

Hecken machte bei der BVMed-Mitgliederversammlung deutlich, dass der Gesetzgeber kurzfristig ein Beratungsverfahren für Verbandmittel wie bei den Arzneimitteln einführen müsse – zumal der Komplexitätsgrad bei Studien für Wundversorgungsprodukte höher und die Studien-Endpunkte komplexer seien als bei Arzneimitteln. Beispielsweise sei die Frage, wie die Verringerung der Wundgröße dargestellt werden könne, methodisch noch nicht geklärt. „Es ist nicht nur im Interesse der Unternehmen, sondern auch im Interesse des G-BA, wenn möglich schon vor dem Beginn von Studien ein Austausch über das Setting und die Endpunkte solcher Studien stattfindet, damit diese am Ende auch tatsächlich verwertbare Evidenz liefern können“, so Hecken. Auch müsste dann noch die Übergangsfrist entsprechend verlängert werden, damit die Hersteller eine Studie auf Basis des mit dem G-BA besprochenen Studiendesigns durchführen können, um schließlich auf dieser Basis den Antrag zur Aufnahme des Produkts in die Anlage V der Arzneimittel-Richtlinie zu stellen. Nach Hecken müssten Verfahren und Regelungsrahmen zudem geeignet sein, um Innovationen den Zugang in die Versorgung zu ermöglichen.

Der BVMed hatte Anfang April 2023 in einem Brandbrief an Bundesgesundheitsminister Karl Lauterbach „dringenden gesetzlichen Handlungsbedarf bei der Wundversorgung im GKV-System“ angemahnt.

Handele der Gesetzgeber nicht, sei absehbar, dass anerkannte, bewährte sowie auf randomisierten kontrollierten Studien basierende Wundauflagen ab dem 2. Dezember 2023 nicht mehr für die Versorgung der chronisch kranken Wundpatient:innen zur Verfügung stehen. Dies werde nach Angaben der BVMed-Expert:innen dramatische Folgen haben:

• Durch den Wegfall entsprechender antimikrobieller Wundversorgungsprodukte werden durch den absehbar höheren Einsatz oraler Antibiotikatherapien die entsprechenden Resistenzen deutlich steigen.
• Ohne den zukünftigen Einsatz der etablierten Wundauflagen mit antimikrobieller Wirkung wird die Anzahl von stationären Aufenthalten unvermeidlich steigen.
• Außerdem wird der Wegfall insbesondere von antimikrobiellen Wundauflagen zu einer zusätzlichen Belastung der Pflege führen.

With its new Trend and Event Platform, the Premium Group presents a new concept for a progressive community. According to Premium Group classic trade fair formats are over - this summer it's all about (re)connection, real emotions and new perspectives. The emphasis lies on the most relevant trends and the power of networking, but in a more personalised and intimate way.

PREMIUM and SEEK are focusing on a more rigorous curation of promising brands and collections as well as various opportunities to connect. An extensive content programme of keynotes, round tables, live interviews, study presentations and panels on the most important trends will offer two diverse and time-efficient days. The areas of concentration encompass sustainability, technology, fashion, business, lifestyle, and beauty. The repertoire of topics include marketing themes such as LinkedIn and Tik Tok, new tech tools such as ChatGPT or Virtual Dressing as well as news from the metaverse. Sustainability topics such as denim, circularity, re-commerce, vintage and the new Green Deal laws will be discussed as well as cross-industry topics such as female empowerment, Gen Z and modern leadership.
     
PREMIUM marks the first event of the season for womenswear. New silhouettes, design trends, provocation and the current zeitgeist are brought to the forefront with a carefully curated selection of brands. The fashion scene and visitors can look forward to the best of denim, hyper-femininity, beauty, well-being, future Berlin icons and innovations from the tech and lifestyle sphere. New talents will also have the opportunity to pitch their labels to a professional audience. SEEK focuses on heritage, Y2K, modern sportswear, outdoor and sustainable brands, which will be shown in the CONSCIOUS CLUB. Other highlights will include talks and inspiring activations from the community.

"We listen, research and curate the most important trends for the industry. To do this, our team of experts travels across Europe and exchange ideas with representatives from the entire industry. The results of months of work can be discovered in two days," says Maren Wiebus, Creative Director of the Premium Group.

Today, attention is the most important currency for the fashion industry. This is also why, for the very first time ever, the Premium Group events will take place over only two days instead of three. At the same time, generally accepted norms and rules are questioned, taken apart, and put back together again. The organisers of Premium Group invite fashion professionals to discuss the rules and redefine them together.
 
The summer editions of PREMIUM and SEEK will take place on 11 and 12 July at the new old location Station-Berlin in the heart of Berlin.

• Spunbond, meltblown and composite structures for new market opportunities

RadiciGroup is participating with its Advanced Textile Solutions business area at Index in Geneva from 18 to 21 April 2023. Among the Group’s products showcased are spunbond and meltblown for different application sectors, such as roofing, construction, automotive, HO.RE.CA. and filtration.

“The key message we are bringing to the fair is sustainability,” noted Enrico Buriani, CEO of the Nonwovens division of RadiciGroup Advanced Textile Solutions. “Those who already know us know that, for many years, the Group has been focused on proposing low environmental impact products and processes where sustainability is scientifically measured or certified by independent third parties. Our company is dedicated to nonwovens, which, by the way, are produced using 100% renewable energy. We have expanded our portfolio of innovative solutions for customers interested in realizing projects with sustainability as an essential requirement.”

Respunsible® is a spunbond brand manufactured from recycled polypropylene. A preliminary Life Cycle Assessment (LCA) study was carried out by RadiciGroup to demonstrate the correlation between the reduction in environmental impact and the percentage increase in recycled material. The final results demonstrate that a variable percentage of from 50 to 70% recycled material leads to a reduction in CO2 emissions of from 30 to 40%, compared to a fabric made of 100% virgin material, without comprising high technical performance.

Additionally, since RadiciGroup has achieved ISCC PLUS certification (International Sustainability and Carbon Certification), it can offer bio, biocircular or circular polypropylene spunbond and meltblown nonwovens, in which the sustainable polypropylene is biomass balanced. This certification signifies traceability along the supply chain and verifies that the certified companies meet high environmental and social standards.

“Since 2020, we have had a technologically advanced meltblown production line,” Mr. Buriani concluded. “This allows us to make composite structures, sold under the brand name Radimelt®. Now our goal is to expand our filtration applications, diversifying and developing new business, for instance vacuum cleaner bags or HVAC (heating, ventilation and air conditioning) system filters, where we can meet the high efficiency and mechanical resistance demanded, thanks to our latest generation technology.”

Der Bundesverband Medizintechnologie (BVMed) hat weitere Infoblätter zu umweltrechtlichen Vorgaben veröffentlicht. Mit den Blättern zu beispielsweise dem Batteriegesetz oder dem Elektrogeräte-Recht unterstützt der Verband Medizintechnik-Unternehmen bei der Umsetzung des Umweltrechts. Der kostenfreie BVMed-Service gibt einen Überblick zu den Anwendungsbereichen und entstehenden Pflichten aus aktuell 14 unterschiedlichen Gesetzen und Verordnungen.

Europa soll der erste klimaneutrale Kontinent werden. Hierfür sind von der EU-Kommission rund 80 Initiativen geplant. Viele davon betreffen direkt oder indirekt die Medizintechnik-Branche. Als Unterstützung für die Einordnung des umfassenden Umweltrechts bietet der BVMed in Zusammenarbeit mit der Produktkanzlei eine Reihe an Infoblättern an. Neu hinzugekommen sind folgende Themen:

• Batteriegesetz (BattG)
• Einwegkunststoff-Kennzeichnungs-Verordnung & -Verbotsverordnung (EWKKennzV & EWKVerbotsV)
• Elektro- und Elektronikgerätegesetz (ElektroG)
• Elektro- und Elektronikgeräte-Stoff-Verordnung (ElektroStoffV)
• Energieverbrauchskennzeichnungs-Verordnung
• F-Gas-Verordnung
• Verordnung über persistente organische Schadstoffe (POP-VO)
• Verordnung zur Registrierung, Bewertung, Zulassung und Beschränkung chemischer Stoffe (REACH-VO)

Die Infoblätter decken folgende Inhalte ab:

• Name und Verkündungsstand des Rechtsaktes
• Hintergrundinformationen (beispielsweise die Umsetzung des europäischen Rechts durch nationale Rechtsakte)
• Beschreibung von Anwendungsbereich und Ausnahmen
• Beschreibung von Betroffenheit/Rollen
• Stichpunkte zu den Pflichten
• Aktuelle Entwicklungen (beispielsweise laufende Gesetzgebungsverfahren oder Ankündigungen in Arbeitsprogrammen)

From April 25^th to 27^th, 2023, the Institute of Textile Machinery and High Performance Material Technology (ITM) of TU Dresden will be exhibiting at the pavilion SAXONY! at JEC World 2023.

The ITM will provide a comprehensive overview of its current research in the field of machine and product development along the entire textile process chain.

The upcoming JEC 2023 exhibition will highlight innovative Customised Connective Cores (CCC), which are custom-made core-insert structures additively manufactured using cellular metal and a form-fit integrated insert. These CCCs can be seamless integrated either as patches or as full-surface core material into lightweight panels, offering significantly improved load-bearing behavior (especially 4 times the load-bearing capacity and fail-safe behavior) compared to existing technologies. This breakthrough opens up new possibilities for fastening lightweight panels.

Another highlight at the exhibition is the repair process for fibre-reinforced composites (FRP) developed at the ITM. Instead of mechanically grinding the damaged area, the matrix in the repair area is locally dissolved using a UV-rays-induced depolymerisation process. Damaged fibres can thus be replaced by a customized repair patch. Free yarn ends on the textile repair patches are spliced with the UV-exposed yarn ends in the repair area using an adapted splicing process. In this way, a very clean, simplified and mechanically improved repair area can be achieved compared to the state of the art.

The diverse possibilities offered by the structure and process simulation of textile high-performance materials and textile manufacturing processes will also be presented. By means of multi-scale modelling and simulation, a profound understanding of materials and processes is achieved at the ITM. Finite element models on the micro, meso and macro scale have been developed and validated for this purpose. Examples from current ITM research projects demonstrate the various possibilities and areas of application of modern simulation methods in the field of textile technology.

Moreover, an innovative process for the integral manufacturing of 3D rib-stiffened preforms with complexly arranged stiffeners in 0°, 90° and ± 45° orientation was developed and successfully implemented at the ITM. Due to the process-integrated structure fixation and the continuous fibre reinforcement between shell and rib structure, the 3D preforms are perfectly suited for the production of highly load-bearing FRP components with increased bending stiffness, which will be exhibited at JEC. Hence, the lightweight construction potential of high-performance fibres can be fully exploited.

A successfully established development are partially flowable 2D textile reinforcement fabrics that are continuously manufactured in one single process step. For this purpose, the entire process chain was developed at the ITM, which allows a cost-effective and high-volume production of load-bearing thermoplastic 3D FRP components with continuous fibre reinforcement between shell and stiffeners.

At JEC 2023, the ITM will also present a partially embedded textile latice girder as reinforcement for carbon concrete applications, which was produced by means of an innovative textile manufacturing process based on the multiaxial warp knitting technology. Through the development of a customized warp insertion, manipulation and take-off system as well as appropriate shaping methods, it is now possible to produce tailored textile semi-finished products, e.g. for use in wall and ceiling panels. These textile latice girders represent a resource-saving alternative to conventional steel girders due to the reduced among of concrete required and the additional cavity for media and cable guidance.

The integration of textile actuators and sensors in FRP provides structures with additional functionalities. The research and application of such interactive FRP with different matrix materials (e.g. with thermoset, elastomer or concrete matrix systems) for structural health monitoring or adaptive systems is one of the key research areas of the ITM.

Moreover, the development and implementation of innovative yarn constructions based on recycled high-performance fibres (e.g. rCF, rGF, rAR) for sustainable FRPs is successfully promoted at ITM. By use of a special carding machine, recycled fibres are opened up, separated and joined to form a wide, uniform ribbon. Subsequently, innovative hybrid yarn constructions made of evenly mixed recycled high-performance and thermoplastic fibres with variable fibre volume fractions can be manufactured by means of various spinning technologies. Selected yarn constructions and components will be showcased at JEC.

The diabetic community has always been a priority for Hologenix, creators of CELLIANT® infrared technology, so the company embarked on an initial study to test the hypothesis that the technology can positively impact diabetic patients with vascular impairment, now published in Journal of Textile Science & Engineering. Another study is underway as well with more research on the horizon.

According to statistics cited in the International Diabetes Federation Diabetes Atlas, 9th edition, globally, close to a half billion people are living with diabetes and that number is expected to increase by more than 50 percent in the next 25 years.
 
The introduction of the study in the Journal of Textile Science & Engineering also reports that diabetic patients frequently suffer from a combination of peripheral neuropathy and peripheral artery disease, which particularly affects their feet. It further states that it has been estimated that the lifetime risk for the development of foot ulcers in diabetic patients can be as high as 25 percent and that the risk of amputation is 10 to 20 times higher than in non-diabetic subjects.
 
The study was performed by Lawrence A. Lavery, D.P.M., M.P.H., a Professor in the Department of Plastic Surgery at UT Southwestern Medical Center. His clinic and research interests involve diabetic foot complications, infections and wound healing, and he participated in the conception, design, implementation and authorship of the Journal of Textile Science & Engineering study.  

CELLIANT technology is a patented process for adding micron-sized thermo-responsive mineral particles to fibers, in this case polyethylene terephthalate (PET) fibers. The resulting CELLIANT yarns were woven into stockings and gloves containing either 82% CELLIANT polyester, 13% nylon and 5% spandex or for the placebo, 82% polyester with no CELLIANT, 13% nylon and 5% spandex. CELLIANT products absorb body heat and re-emit the energy back to the body as infrared energy, which is non-invasive and increases temporary blood flow and cell oxygenation levels in the body.

The objective of the study was to “evaluate changes in transcutaneous oxygen (TcPO2) and peripheral blood flow (laser Doppler, LD) in the hands and feet of diabetic patients with vascular impairment when CELLIANT gloves and stockings are worn.” While there was not a statistically significant result across all subjects, the study did show that some patients wearing CELLIANT stockings for 60 minutes had an increase of as much as 20% in tissue oxygenation and 30% in localized blood flow. According to the study’s conclusion, “the trends that were observed in favor of CELLIANT stockings suggest that a larger well-designed clinical trial should be undertaken and may provide evidence of clinical efficacy in treatment of the diabetic foot.”
 
The study also notes that “There have been no documented or observed side effects of wearing CELLIANT stockings, and they are relatively inexpensive compared to conventional pharmaceutical interventions.”

Hologenix has embarked on a more comprehensive trial, “Study to Evaluate CELLIANT Diabetic Medical Socks to Increase Tissue Oxygenation and Incidence of Complete Wound Closure in Diabetic Foot Wounds” – NCT04709419, which focuses on the impact of CELLIANT technology to potentially improve tissue oxygenation and wound healing outcomes.
 
“We are excited to explore whether future studies of infrared, with its most common biological effects of increased localized blood flow and cellular oxygenation, could result in a breakthrough in diabetic patients with vascular impairment,” said Seth Casden, Hologenix Co-founder and CEO. “We see a huge potential opportunity with this research for helping to fulfill our core mission of improving people’s health and well-being by potentially reducing the impact of diabetes, and we are actively seeking partners to expand our research efforts.”

On 30 March 2022, the European Commission presented its vision for the future of the textile industry. The strategy mainly focuses on reducing the environmental footprint and promote sustainability and transparency in the value chain.

EURATEX has welcomed the publication of the strategy, as it recognises the strategic importance of the European textile industry, and its core competitive values of quality and creativity. At the same time, the association has warned that translating that vision into reality is a delicate process, as the industry needs to reconcile sustainability with competitiveness. Making the green (and digital) transition should make companies stronger; the benefits should outweigh the costs.

This premise had a serious blow by the Russian war in Ukraine, which erupted at almost the same time when the strategy was launched, and has dramatically changed the economic context. Energy prices increased by a factor of 10 (!), putting the European industry at a significant disadvantage with its global competitors, leading to company shutdowns or relocations. Extended lock downs in China and defensive trade policies in the US and elsewhere have further generated uncertainty on the market and disrupted supply chains.

Today, one year after its publication, EURATEX remains carefully optimistic about the implementation of the strategy, but needs to warn against some important pitfalls on the road ahead.

1. Despite these turbulent times, the Commission is moving ahead “swiftly” in translating their EU Textile Strategy into (draft) legislation. At present, at least 16 pieces of legislation are on the table, which will turn the textile industry into a strictly regulated sector. The quality of this new regulatory framework is critical to the success of the strategy: upcoming rules need to be coherent, technically feasible and enforceable, and have a minimal cost for SMEs. EURATEX calls for a realistic timetable and “competitiveness test” for each piece of legislation before it is adopted.
2. Textile companies need to be informed and supported to comply with this new framework. This requires substantial funding which should be earmarked exclusively to the sector, covering areas of innovation and digitalisation, skills development, support to start ups and internationalisation, as well as access to affordable energy. In this regard, EURATEX calls on the Commission to translate the current “good intentions” into concrete decisions.
3. The EU strategy will not work if there is no demand for sustainable textiles, both from individual consumers and public authorities (procurement). Concrete measures need to be taken to offer a competitive advantage to sustainable and high quality textile products, e.g. through a different VAT rate, strict procurement rules, closer cooperation between the brands/retailers, producers and consumers.
4. The EU strategy could also fail, if the global dimension of the textile industry is ignored. Up to 80% of clothing products are produced outside the EU; these products need to comply with the new framework, but it remains unclear how to ensure that level playing field. Market surveillance needs to be stepped up massively – also targeting on line sales – but this would require significant efforts from member states, which are not available as of today.

Despite these important challenges, EURATEX remains committed to the successful implementation of the EU Textile Strategy. Director General Dirk Vantyghem commented: “We want to be a global leader in sustainable textiles, building on the entrepreneurship, quality and creativity of nearly 150,000 European textile companies. Creating this new framework is an incredible challenge, requiring a close dialogue between the industry and the regulator. But if well designed and carefully implemented, it can set a new era for the European textile industry”.

• Electromagnetically heatable nanomodified stent for the treatment of hollow organ tumours wins second place at the RWTH Innovation Award

Almost every fourth person who dies of cancer has a hollow organ tumour, for example in the bile duct or in the oesophagus. Such a tumour cannot usually be removed surgically. It is only possible to open the hollow organ for a short time using a stent, i.e. a tubeshaped prosthesis. However, the tumour grows back and penetrates the hollow organ through the stent. Ioana Slabu from the Institute of Applied Medical Technology and Benedict Bauer from the Institut für Textiltechnik of RWTH Aachen University have now developed a novel technology for the therapy of hollow organ tumours, which was awarded second place in the RWTH Innovation Award. This involves a polymerstent that contains magnetic nanoparticles. When electromagnetic fields are applied, these nanoparticles lead to a controlled heating of the stent material and thus of the tumour. Because the tumour reacts much more sensitively to heat than healthy tissue, it is destroyed and the hollow organ remains open. Thus, the stent develops a self-cleaning effect.  

Ioana Slabu of the AME explains: "Not only can we drastically reduce treatment costs, but above all we can provide relief for millions of patients worldwide.
 
A manufacturing process and proof of concept for magnetic hyperthermia are already in place. This novel technology has a very high development potential because it can also be used for tumours in other parts of the body such as the prostate, stomach, intestine or urinary bladder or for cardiovascular diseases.  

The AiF/IGF project started under the project title "ProNano" funded by BMWK. Now the approval for the follow-up project "ProNano2" has also been received. The approved project is called: "Validation of the innovation potential of heatable stents for heat-induced treatment of cavity tumours" and is funded by BMBF in course of the VIP+ program. With the Clinic for General, Visceral and Transplantation Surgery of the University Hospital Aachen and the Institute for Technology and Innovation Management at RWTH Aachen University, the consortium is enriched by clinical and economic expertise. Every year, RWTH Aachen University honours particularly innovative university projects with the Innovation Award. Professor Malte Brettel, Prorector for Business and Industry, presented the certificates to four outstanding projects as part of RWTHtransparent.